Business development

Navamedic´s strategy is to build a strong growing Nordic pharmaceutical company based on the sales of own and inlicensed products.

The majority of the business has during 2010 been ties to the subsiduary Vitaflo Scandinava that represents more than 20 different producers world-wide and currently markets a portfolio of more than 45 products in Sweden, Denmark, Finland, Norway and Holland. Navamedic has the ambition to grow in excisting and new territories with new and excisting products. 

Navamedic has via the cooperatin with Aspen Healthcare the ambition to establish itself as a major player within generic pharmaceuticals in the Nordic countries as well as in the BeNeLux. Navamedic wants to be the partner of choice for companies wishing to establish themselves in the Nordics. Navamedic´s subsidiary Vitaflo is constantly seeking products to complement the existing portfolio within their focus knowledge areas:

  • Medical Nutrition
    		•
  • Anasthesia / Pain
    		•
  • Oral Medicin
    		•
  • Gastro
    		•
  • Female Care
    		•
  • Neurology
    		•
  • Dermatology
    		•
  • Osteoarthritis
    		•
  • Abuse treatment
    		•
  • Oncology
    		•

    The company is looking for possible acquisitions of products and/or companies in order to extend our portfolio and our geographical footprint in addition to in-licensing agreements. Our home market is the Nordic countries/Scandinavia where we have our own sales force. In addition we have an extensive network of partners throughout Europe whom we can work with, if there are deals covering larger markets. 

    If you want to discuss a potential business development opportunity please contact CEO Olof Milveden, email: om [at] navamedic [dot] com